Intercontinental Wealth Advisors, LLC Moderna, Inc. Transaction History

Intercontinental Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $2.95 Million - $5.23 Million	-24,891 Reduced 94.55%	1,436 $257,000
Q3 2022 Nov 10, 2022	BUY	$118.07 - $194.18 $1.67 Million - $2.75 Million	14,154 Added 116.27%	26,327 $3.11 Million
Q2 2022 Aug 05, 2022	BUY	$117.13 - $176.59 $149,106 - $224,799	1,273 Added 11.68%	12,173 $1.74 Million
Q1 2022 May 09, 2022	BUY	$126.46 - $235.05 $1.38 Million - $2.56 Million	10,900 New	10,900 $1.88 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Intercontinental Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Intercontinental Wealth Advisors, LLC with notifications on news.